AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into...(ent of its product pipeline by2010. In 2...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
Date:10/29/2007
ent of its product pipeline by 2010. In 2007, AstraZeneca accelerated achievement of this biologics strategy through the successful acquisition of MedImmune, a fully integrated biotechnology company and one of the world's ten largest within the industry,
About the New MedImmune
MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is dedicated to advancing science and medicine to help people live better lives and is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.
'/>"/>
| SOURCE MedImmune, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. The worldwide growth of ag biotech
2. Midwest holds strong position in worldwide diagnostics business
3. Globalization of biotech industry is a decidedly worldwide phenomenon
4. EraGen cystic fibrosis test to be distributed worldwide through Bayer
5. UW Academic ADL Co-Lab joins worldwide effort against slavery
6. Glacial records depict ice age climate in synch worldwide
7. AIDS and tobacco are worldwide killers: Is bioscience doing enough to stop them?
8. Oskar Anderson to succeed Miszewski as head of state technology division
9. Metavante forms cash-management division
10. Metavante expands healthcare payments division
11. Quintessence division to develop drug tests with NIH grant
Post Your Comments:
Breaking Biology Technology:Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3
Other Biology Technology:CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 2CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 3Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 2Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 3Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer 2
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 1DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 2DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 3DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 4DOE to Explore Scientific Cloud Computing at Argonne Lawrence Berkeley National Laboratories 14470 5Choyce Peterson Goes the Extra Mile for Visiting Nurses 59452 1Choyce Peterson Goes the Extra Mile for Visiting Nurses 59452 2VirtualScopics to Present at the 8th Annual Bio Investor Forum 5470 1VirtualScopics to Present at the 8th Annual Bio Investor Forum 5470 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |